Medicare Will Continue to Cover Expensive Cancer Drugs - NYTimes.com

Medicare Will Continue to Cover Expensive Cancer Drugs - NYTimes.com: "Medicare confirmed on Thursday that it would continue to pay for two expensive cancer drugs that had been at the center of debate — Avastin from Genentech for breast cancer and Provenge from Dendreon for prostate cancer."